Carillion Alawi awarded $316mn Sultan Qaboos Hospital contract

By Sophie Chapman
Share
The infrastructure solutions company, Carillion Alawi, has won a OMR121.6mn (US$316m) contract for work on the Sultan Qaboos Hospital project in Oman...

The infrastructure solutions company, Carillion Alawi, has won a OMR121.6mn (US$316m) contract for work on the Sultan Qaboos Hospital project in Oman.

Carillion Alawi is a 50:50 joint venture between the Zawawi family and UK-based Carillion plc.

The project will commence as soon as Oman’s Ministry of Health has finalised the contract, and will cover a 20-hectare area of land in Salalah.

The company will develop a seven-storey building with an initial capacity for 620 beds.

SEE ALSO:

Carillion Alawi signed “a letter of award with the Oman Ministry of Health as the preferred bidder [for] the design and build of the new Sultan Qaboos Hospital” according to a statement on their website.

The development on the project will progress in two stages – the first being initial design and mobilisation activities.

The first stage will begin immediately, and will be funded by “the customer”. The second stage is expected to start in 2018 following the completion of the design.

The UK company, Carillion, said that the contract was “on similar terms to those for the Salalah award and, if it were to go ahead, would have an estimated value of $158m (OMR60.8m) to the JV”.

The contract is being procured through “lower risk” routes, which entails “seeking support from UK Export Finance to secure [funding] for customers”.

Share

Featured Articles

How Huawei's Digital Solutions are Transforming Healthcare

Offering network, cloud, and AI solutions, Huawei is able to help healthcare providers deliver better outcomes for patients

2024 Nestlé Nutrition Symposium Explored Food & Health

Nestlé manufactures 4.5m KitKats every day, but the food giant is also focused on advancing food nutrition, as explored at the 2024 International Symposium

Thirona’s AI Tech is Creating Individualised Patient Care

Eva van Rikxoort, CEO and Founder of Thirona, tells us how AI technology is advancing lung imaging and bringing more individualised treatment to patients

AstraZeneca’s Discovery Centre, Constructed by Mace Group

Technology & AI

NeoGenomics: Data in Oncology Testing & Diagnostics

AI & ML

Samsung’s New Health Software Development Kit Suite

Digital Healthcare